EDIT vs HCA · rev $32.3M vs P/E 17, rev $75.60B
Editas Medicine Inc (EDIT) versus HCA Holdings Inc (HCA) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
HCA Holdings Inc (HCA) is a medical care facilities company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported HCA revenue for 2025-12-31 was $75.60B. Net income was $6.78B. Revenue was up 7.1% from 2024-12-31 to 2025-12-31. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
EDIT currently screens at market cap $375.2M. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
Not investment advice. Open the EDIT and HCA stock pages for the full models.
Not investment advice.